Announce topline data from the Phase 2b CARPO trial of Auxora
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 22 Jan 2024
- Due
- 30 Jun 2024
- Delivered
- 27 Jun 2024
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“topline data (expected 1H 2024) from the CalciMedica’s Phase 2b CARPO trial of Auxora”
What we found
Evidence strength B What the grades mean
CalciMedica announced positive topline data from the Phase 2b CARPO trial of Auxora on June 27, 2024, within the 1H 2024 deadline.
-
B CalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora in Acute Pancreatitis (AP) Company press release announcing topline results from CARPO Phase 2b trial
-
C CalciMedica to Host Conference Call to Review Topline Data from Phase 2b CARPO Trial of Auxora in Acute Pancreatitis Conference call announcement for June 27, 2024 to discuss topline data
Checked 21 Sep 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Announce
- Language
- Expected (“expects”, “plans”)
How this entry was checked
- Commitment recordedRecorded from the company's filing.
- First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Gemini (Google), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you CalciMedica, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2024-CALC-000026 · Corrections policy